Tumor necrosis factor inhibitors for rheumatoid arthritis

N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / physiopathology
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Practice Guidelines as Topic
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept